The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression
MMI launch their latest solution at the AACR meeting in Chicago: CellScan
The latest technologies from ZEISS help doctors advance ophthalmic care with new ways to see pathology and maximize clinical efficiency and performance
Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Alexandra Knauer from KNAUER Wissenschaftliche Geräte swoops the award with her excellency in leadership and entrepreneurship
Read the story of a microvolume spectrophotometer demo instrument that impressed scientists so much it became the unanimous choice at the Royal Veterinary College, UK
